Impaired surface ??? GABA(A) receptor expression in familial epilepsy due to a GABRG2 frameshift mutation.
Ontology highlight
ABSTRACT: The purpose of the study was to explore the pathogenic mechanisms underlying generalized epilepsy and febrile seizures plus (GEFS+) in a family with a novel ?2 subunit gene (GABRG2) frameshift mutation. Four affected and one unaffected individuals carried a c.1329delC GABRG2 mutation resulting in a subunit [?2S(S443delC)] with a modified and elongated carboxy-terminus that is different from that of the wildtype ?2S subunit. We expressed the wildtype ?2S subunit and the predicted mutant ?2S(S443delC) subunit cDNAs in HEK293T cells and performed immunoblotting, flow cytometry and electrophysiology studies. The mutant subunit was translated as a stable protein that was larger than the wildtype ?2S subunit and was retained in the ER and not expressed on the cell surface membrane, suggesting GABRG2 haploinsufficiency. Peak GABA-evoked currents recorded from cells cotransfected with wildtype ?1 and ?2 subunits and mutant ?2S subunits were significantly decreased and were comparable to ?1?2 receptor currents. S443delC is the first GABR epilepsy mutation predicted to abolish the natural stop codon and produce a stop codon in the 3' UTR that leads to translation of an extended peptide. The GEFS+ phenotype observed in this family is likely caused by ?2S subunit loss-of-function and possibly to dominant-negative suppression of ?1?2?2 receptors. Many GABRG2 truncation mutations result in GEFS+, but the spectrum of phenotypic severity is wider, ranging from asymptomatic individuals to the Dravet syndrome. Mechanisms influencing the severity of the phenotype are therefore complex and difficult to correlate with its demonstrable functional effects.
SUBMITTER: Tian M
PROVIDER: S-EPMC3762699 | biostudies-literature | 2013 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA